Literature DB >> 16050715

A Facile method to transform trans-4-carboxy-3,4-dihydro-3-phenyl- 1(2H)-isoquinolones to indeno[1,2-c]isoquinolines.

Xiangshu Xiao1, Mark Cushman.   

Abstract

The indeno[1,2-c]isoquinolines are an important class of topoisomerase I inhibitors with anticancer activity. The condensation of Schiff bases with homophthalic anhydrides provides a mixture of cis- and trans-4-carboxy-3,4-dihydro-3-phenyl-1(2H)isoquinolones. Although the cis products can be readily converted to indeno[1,2-c]isoquinolines with thionyl chloride, the trans products do not afford indeno[1,2-c]isoquinolines using this method. The present report describes a route for conversion of the trans diastereomers to indeno[1,2-c]isoquinolines using selenoxide elimination and Friedel-Crafts cyclization chemistry.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16050715      PMCID: PMC2526351          DOI: 10.1021/jo050831t

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  16 in total

1.  Synthesis of new indeno[1,2-c]isoquinolines: cytotoxic non-camptothecin topoisomerase I inhibitors.

Authors:  M Cushman; M Jayaraman; J A Vroman; A K Fukunaga; B M Fox; G Kohlhagen; D Strumberg; Y Pommier
Journal:  J Med Chem       Date:  2000-10-05       Impact factor: 7.446

2.  Synthesis of new dihydroindeno[1,2-c]isoquinoline and indenoisoquinolinium chloride topoisomerase I inhibitors having high in vivo anticancer activity in the hollow fiber animal model.

Authors:  Muthusamy Jayaraman; Brian M Fox; Melinda Hollingshead; Glenda Kohlhagen; Yves Pommier; Mark Cushman
Journal:  J Med Chem       Date:  2002-01-03       Impact factor: 7.446

3.  Synthesis of cytotoxic indenoisoquinoline topoisomerase I poisons.

Authors:  D Strumberg; Y Pommier; K Paull; M Jayaraman; P Nagafuji; M Cushman
Journal:  J Med Chem       Date:  1999-02-11       Impact factor: 7.446

4.  Synthesis and anticancer activity of simplified indenoisoquinoline topoisomerase I inhibitors lacking substituents on the aromatic rings.

Authors:  Muthukaman Nagarajan; Andrew Morrell; Brian C Fort; Marintha Rae Meckley; Smitha Antony; Glenda Kohlhagen; Yves Pommier; Mark Cushman
Journal:  J Med Chem       Date:  2004-11-04       Impact factor: 7.446

5.  Dihydroindenoisoquinolines function as prodrugs of indenoisoquinolines.

Authors:  Xiangshu Xiao; Ze-Hong Miao; Smitha Antony; Yves Pommier; Mark Cushman
Journal:  Bioorg Med Chem Lett       Date:  2005-06-02       Impact factor: 2.823

6.  Design, synthesis, and biological evaluation of indenoisoquinoline topoisomerase I inhibitors featuring polyamine side chains on the lactam nitrogen.

Authors:  Muthukaman Nagarajan; Xiangshu Xiao; Smitha Antony; Glenda Kohlhagen; Yves Pommier; Mark Cushman
Journal:  J Med Chem       Date:  2003-12-18       Impact factor: 7.446

7.  Design, synthesis, and biological evaluation of cytotoxic 11-aminoalkenylindenoisoquinoline and 11-diaminoalkenylindenoisoquinoline topoisomerase I inhibitors.

Authors:  Xiangshu Xiao; Smitha Antony; Glenda Kohlhagen; Yves Pommier; Mark Cushman
Journal:  Bioorg Med Chem       Date:  2004-10-01       Impact factor: 3.641

8.  Design, synthesis, and biological evaluation of cytotoxic 11-alkenylindenoisoquinoline topoisomerase I inhibitors and indenoisoquinoline-camptothecin hybrids.

Authors:  Brian M Fox; Xiangshu Xiao; Smitha Antony; Glenda Kohlhagen; Yves Pommier; Bart L Staker; Lance Stewart; Mark Cushman
Journal:  J Med Chem       Date:  2003-07-17       Impact factor: 7.446

9.  Synthesis of nitrated indenoisoquinolines as topoisomerase I inhibitors.

Authors:  Andrew Morrell; Smitha Antony; Glenda Kohlhagen; Yves Pommier; Mark Cushman
Journal:  Bioorg Med Chem Lett       Date:  2004-07-16       Impact factor: 2.823

10.  Differential induction of topoisomerase I-DNA cleavage complexes by the indenoisoquinoline MJ-III-65 (NSC 706744) and camptothecin: base sequence analysis and activity against camptothecin-resistant topoisomerases I.

Authors:  Smitha Antony; Muthusamy Jayaraman; Gary Laco; Glenda Kohlhagen; Kurt W Kohn; Mark Cushman; Yves Pommier
Journal:  Cancer Res       Date:  2003-11-01       Impact factor: 12.701

View more
  2 in total

1.  Design, synthesis, and evaluation of dibenzo[c,h][1,6]naphthyridines as topoisomerase I inhibitors and potential anticancer agents.

Authors:  Evgeny Kiselev; Thomas S Dexheimer; Yves Pommier; Mark Cushman
Journal:  J Med Chem       Date:  2010-11-23       Impact factor: 7.446

2.  Dibenzo[c,h][1,5]naphthyridinediones as topoisomerase I inhibitors: design, synthesis, and biological evaluation.

Authors:  Evgeny Kiselev; Nicholas Empey; Keli Agama; Yves Pommier; Mark Cushman
Journal:  J Org Chem       Date:  2012-05-15       Impact factor: 4.354

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.